Business Context and Reporting Period
This Form 8-K filing by Bruker Corporation (Delaware) was submitted on June 22, 2017, with a report date of June 28, 2017. The filing addresses Item 5.02 regarding the departure of a director and subsequent board adjustments.
Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes.
Material Changes
- Director Departure: Mr. Chris van Ingen informed the Company of his intention to retire from the Board of Directors, including the Audit and Nominating Committees, effective June 30, 2017. The retirement was due to medical reasons.
- Director Passing: The Company reported the death of Mr. van Ingen on June 27, 2017. He had served on the Board since 2012.
- Board Appointments: To fill committee vacancies, independent director Richard Packer was appointed to the Audit Committee, and lead independent director William Linton was appointed to the Nominating Committee, effective July 1, 2017.
- Board Size Reduction: The Board approved a reduction in size from thirteen to twelve members, effective July 1, 2017, with each of the three Board classes consisting of four members.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or discussion of business risks. Management expressed gratitude for Mr. van Ingen's leadership and extended condolences to his family, noting his departure was not related to any disagreement with the Company.
Key Facts for Investor Verification
- Confirm the effective date of the Board size reduction (July 1, 2017).
- Verify the new composition of the Audit and Nominating Committees following the appointments of Richard Packer and William Linton.
- Note that the departure of Mr. van Ingen was due to medical reasons and not operational disagreements.